IP Library Granted Patent US 10,577,587
Granted Patent B2
US 10,577,587 · App. 15/512,798 · Granted Mar 3, 2020

Method of inducing bone formation by ex-vivo osteoblast culturing for implantation

Inventor: Satyen Sanghavi (Mumbai, IN)
Assignee: REGROW BIOSCIENCES PRIVATE LIMITED
C12N5/0654A61K35/32A61L27/02A61L27/3821A61L27/3847A61L27/54A61L2430/02C12N2500/00C12N2500/02C12N2506/1353
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,577,587
App. No.
15/512,798
Granted
Mar 3, 2020
Kind
B2
Abstract

An ex-vivo culturing method of osteoblasts for implantation, comprising a culturing of adult live osteoblasts as an ex-vivo procedure. The ex-vivo culture, which leads to the formation of the active substance, further comprises the steps of isolation of osteo-progenitor cells, differentiation of osteo-progenitor cells in to osteoblasts, expansion culture, cell culture harvest and wash followed by filling and packaging. This method is instrumental in accelerating the process of bone formation.

Claims (20)

1. A method of inducing bone formation by ex-vivo osteoblast culturing for implantation, comprising:

a) isolating osteo-progenitor cells from a harvest of a subject;

b) differentiating the osteo-progenitor cells in to osteoblasts;

c) expanding the osteoblasts for proliferation into an ex-vivo osteoblast growth culture;

d) harvesting and washing the ex-vivo osteoblast growth culture;

e) sub-culturing the ex-vivo osteoblast growth culture until the ex-vivo osteoblast growth culture reaches not less than 48 million cells to obtain an ex-vivo osteoblast culture;

f) selecting an ex-vivo osteoblast culture for implantation from the characterized ex-vivo osteoblast culture by flow cytometry (FACS) with CD44+, CD151+, and CD105− expression markers;

g) collecting the selected ex-vivo osteoblast culture in Dulbecco's Modified Eagle's Medium (DMEM) to obtain an ex-vivo osteoblast culture for implantation; and

h) injecting the collected ex-vivo osteoblast culture for implantation into a subject and examining bone formation and regeneration.

2. The method as claimed in claim 1 , wherein the harvest of a subject is from a posterior-superior iliac crest or sternum.

3. The method as claimed in claim 1 , wherein the isolating of osteo-progenitor cells includes separating of nucleated bone marrow cells.

4. The method as claimed in claim 3 , wherein the separating of nucleated bone marrow cells is followed by washing of the nucleated bone marrow cells with DMEM culture medium.

5. The method as claimed in claim 1 , wherein the differentiating the osteo-progenitor cells includes replenishing of differentiation medium in culture flasks.

6. The method as claimed in claim 1 , wherein the expanding the osteoblasts further includes transferring of culture flasks to a CO 2 incubator at a temperature range of 37-38 degree Celsius.

7. The method as claimed in claim 6 , wherein the CO 2 incubator is conditioned at a range of 5% CO 2 content.

8. The method as claimed in claim 6 , wherein the CO 2 incubator is humidified at 80%.

9. The method as claimed in claim 1 , wherein the harvesting step further includes centrifuging the ex vivo osteoblast growth culture or the ex-vivo osteoblast culture at a range of 1300-1500 rpm for five-six minutes.

10. The method as claimed in claim 9 , wherein the centrifuging is followed by washing of the ex-vivo osteoblast growth culture or the ex-vivo osteoblast culture with DMEM.

11. The method as claimed in claim 1 , wherein the ex-vivo osteoblast culture for implantation are filled in sterile vials, sealed effectively under aseptic conditions, transported at 2 to 8 degrees Celsius and used as active substance within 72 hours from date of manufacture.

12. The method as claimed in claim 1 further wherein the bone formation and regeneration at the site of induction of bone formation post implantation exhibits approximately ninety percent of bone regeneration on completion of ninety days.

Assignments (2)
CHANGE OF NAME Recorded Apr 18, 2019
From: REGENERATIVE MEDICAL SERVICES PRIVATE LIMITED
To: REGROW BIOSCIENCES PRIVATE LIMITED
Reel/Frame 048945/0709 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2017
From: SANGHAVI, SATYEN; JASWANTRAI DOSHI, VISHAL
To: REGENERATIVE MEDICAL SERVICES PVT. LTD.
Reel/Frame 041653/0687 →
Priority Claims (1)
IN 3005/MUM/2014 · Sep 19, 2014 · national
Continuity (1)
Related Publication 20170292114A1 · Oct 12, 2017